Covered recipient · General Payments record
ANNA C RUELBERG
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,620.68
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $484.91 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $84.36 | 5 |
| Novo Nordisk AS | $84.03 | 5 |
| Abbott Laboratories | $78.95 | 4 |
| Lilly USA, LLC | $71.00 | 4 |
| Acerta Pharma LLC | $49.22 | 3 |
| PFIZER INC. | $44.21 | 3 |
| Amgen Inc. | $37.35 | 2 |
| Daiichi Sankyo Inc. | $20.97 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.65 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125341431 | CMS |
| Abbott Laboratories | $16.73 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125341433 | CMS |
| Abbott Laboratories | $20.99 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125341435 | CMS |
| Abbott Laboratories | $22.58 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125341437 | CMS |
| ABBVIE INC. | $16.89 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108123170 | CMS |
| ABBVIE INC. | $15.20 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108123172 | CMS |
| ABBVIE INC. | $13.62 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108123174 | CMS |
| ABBVIE INC. | $14.74 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108123176 | CMS |
| ABBVIE INC. | $23.91 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108123178 | CMS |
| Amgen Inc. | $22.76 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072859 | CMS |
| Amgen Inc. | $14.59 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072866 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.15 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105716932 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.92 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104559566 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.15 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104639173 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.82 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086354906 | CMS |
| Daiichi Sankyo Inc. | $20.97 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089476565 | CMS |
| Lilly USA, LLC | $18.22 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135448329 | CMS |
| Lilly USA, LLC | $18.16 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135529834 | CMS |
| Lilly USA, LLC | $18.77 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135526213 | CMS |
| Lilly USA, LLC | $15.85 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135473956 | CMS |
| Novo Nordisk Inc | $17.18 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100469634 | CMS |
| Novo Nordisk Inc | $16.00 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100361503 | CMS |
| Novo Nordisk Inc | $17.65 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100579560 | CMS |
| Novo Nordisk Inc | $18.51 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100395274 | CMS |
| Novo Nordisk Inc | $14.69 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100232786 | CMS |
| PFIZER INC. | $14.64 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131061211 | CMS |
| PFIZER INC. | $14.06 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131680065 | CMS |
| PFIZER INC. | $15.51 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131838470 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.